O

Option Care Health

Largest independent home infusion therapy provider

Infusion Nurse 2

Part-TimePosted on 10/19/2026
$40.78 - $67.97+ 401(k) Match
Junior
Bachelor's
Reno, NV, USA
In PersonTravel up to 100% of the time for business purposes.
Medical, Clinical & VeterinaryNursing & Frontline Patient Care

About the job

Requirements
  • An active and unrestricted registered nurse license in the state of practice is required.
  • At least one year of nursing experience is required.
  • Current CPR certification is required, and an in-person class is required by company policy.
  • Demonstrated competency in patient care standards and infusion skill sets applicable to agency programs and service needs is required; advanced certification and training are required as applicable.
  • A valid license to operate a motor vehicle in the state of practice, access to a vehicle for business travel, and proof of liability insurance are required.
  • Basic knowledge of computer operating systems and software applications, with the ability to use nursing technology tools to communicate and document care, is required.
  • Ability to lift up to 50 pounds, with a maximum lift of 75 pounds, and meet the stated physical demands of the job is required.
  • The role requires the physical ability to perform cardiopulmonary resuscitation and related emergency response duties, with periodic reevaluation as applicable.
  • Ability to travel up to 100% of the time for business purposes is required.
  • Compliance with required safety precautions and protective equipment is required when performing the work.
Responsibilities
  • Initiate, develop, and implement intermediate nursing plan-of-care treatments; evaluate patient progress toward goals; organize and participate in direct patient care; perform treatments; administer medications; and educate patients and families or caregivers.
  • Modify the plan of treatment in response to changes in patient status or physician orders to achieve established or revised patient-care goals.
  • Assess patient needs and physical status at each skilled visit through health-data access and patient interviews; reassess needs based on physical findings, therapy response, and supplemental physician orders.
  • Obtain and clarify physician orders for plan-of-treatment revisions, promptly inform physicians of significant changes in patient condition, and provide written summaries to physicians with supplemental orders.
  • Provide training and mentorship to Infusion Nurse I staff as needed to support patient safety and compliance.
  • Teach patients and families using a patient-centered approach to support independence with prescribed therapy and care needs and achievement of plan-of-treatment goals.
  • Communicate with the clinical team, medical providers, patients, and families or caregivers to facilitate continuity of care.
  • Prepare clinical documentation in real time during visits and submit it to the nursing department within established timelines; complete documentation legibly and follow approved abbreviation and correction practices.
  • Coordinate discharge planning, prepare discharge summaries and patient instructions, and report patient-care needs, progress, and goals when transferring care.
  • Comply with agency operations, company policies and procedures, professional standards, applicable local, state, and federal regulations and guidelines, and accreditation standards.
  • Use computers and automation technologies to validate plan-of-treatment orders and communicate patient care; follow the assigned visit schedule to maximize work efficiency.
  • Respond promptly and appropriately to patient requests and initiate emergency procedures when necessary.
  • Maintain ethical and professional conduct and follow established programs and practices consistent with company policies, procedures, mission, values, and objectives.
  • Safeguard confidential patient and company information in accordance with legal and ethical guidelines, including HIPAA requirements.
  • Explain the company’s scope of services and instruct patients about related financial obligations and service charges.
  • Attend and complete required training modules, in-services, and continuing education to maintain competency and professional licensure and demonstrate knowledge of care management in home and alternate-care settings.
  • Provide oversight and coordination of paraprofessionals in the home setting and, when applicable under state and federal regulations, act as supervisor in the absence of the supervisor or nurse manager.
  • Participate in multidisciplinary team conferences and provide precepting, training, and mentoring to nurses for orientation, onboarding, and assigned supervisory activities.
  • Participate in nursing-department on-call responsibilities.
  • Insert PICC lines or midlines per physician order when applicable.
  • Troubleshoot and declot obstructed central-line catheters when applicable.
  • Monitor PICC lines or midlines and educate patients on line-infection prevention and routine care when applicable.
  • Perform other related duties as directed by the supervisor.
Desired Qualifications
  • A Bachelor of Science in Nursing from an accredited school of nursing is preferred.
  • One to two years of previous infusion nursing experience is preferred.

About the company

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bannockburn, Illinois

Founded

1979

Get referred to Option Care Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 29, 2026 Q2 revenue reached $1.44 billion, while acute therapy and IG Neuro strengthened.
  • Management stabilized CID patient census in Q2 2026 and kept full-year revenue guidance unchanged.
  • The company repurchased $150 million in Q2 2026, signaling confidence and shareholder-return capacity.

What critics are saying

  • August 2026 guidance still bakes in a 600-basis-point CID revenue headwind and $55 million gross profit hit.
  • July 29, 2026 Q2 buyback of $150 million masks weak top-line momentum and analyst skepticism.
  • Biosimilar erosion and payer reverification pressure can permanently shrink chronic volumes if retention stays broken.

What makes Option Care Health unique

  • Option Care Health leads U.S. independent home and alternate-site infusion, with nationwide clinician density.
  • Its payer, biopharma, and prescriber relationships create switching costs across chronic and acute therapies.
  • August 27, 2026 guidance shows durable cash generation, with at least $320 million operating cash flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Time Off
  • Bonding Time Off
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Health Savings Account/Flexible Spending Account
  • Flexible Spending Accounts
  • Tuition Reimbursement
  • Family Support
  • Mental Health Support

Company News

AD HOC NEWS
Oct 15th, 2026
McKesson commits $1.4B for 49% stake in Option Care at $5.8B valuation

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

Yahoo Finance
Oct 6th, 2026
McKesson and Clayton Dubilier & Rice near $5B deal to acquire Option Care Health

Option Care Health shares jumped 33.2% in pre-market trading after the Financial Times reported McKesson and Clayton Dubilier & Rice are nearing a transaction valued at over $5 billion to acquire the alternate site health provider. According to the report, the deal would involve the two firms partnering to buy the infusion services provider, which they view as undervalued. Large-scale buyout discussions typically drive market optimism as investors anticipate acquisition premiums. The move is significant for Option Care Health, whose shares have experienced 13 movements greater than 5% over the past year. At $31.03 per share, the stock is trading 15.2% below its 52-week high but remains down 3.8% year-to-date.

Central Charts
Oct 6th, 2026
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have

Yahoo Finance
Jul 29th, 2026
Option Care Health Q2 beats expectations with $1.4B revenue, narrows full-year guidance

Option Care Health reported second-quarter 2026 results that exceeded expectations. Revenue rose 7% sequentially to $1.4 billion, whilst adjusted EBITDA increased 12% to $117.5 million and adjusted EPS reached $0.45. Operating cash flow totalled $184 million. Acute therapies posted high-single-digit organic growth, while chronic revenue improved sequentially as the CID portfolio began to stabilise. However, CID-related pressure is expected to reduce 2026 revenue by roughly 600 basis points and gross profit by $55 million. The home and alternate-site infusion provider maintained its full-year revenue guidance at $5.675 billion to $5.775 billion. Adjusted EBITDA guidance was narrowed to $480 million to $495 million, and adjusted EPS guidance to $1.85 to $1.92. The company repurchased $150 million of shares, nearly 5% of shares outstanding.

Yahoo Finance
Jul 29th, 2026
Option Care Health reports $1.44B Q2 revenue, up 1.9%, and raises $150M share buyback

Option Care Health, the largest independent provider of home and alternate site infusion services in the US, reported second quarter 2026 results. Net revenue reached $1.44 billion, up 1.9% year-over-year. The company posted net income of $53.9 million, up 6.7%, with diluted earnings per share of $0.35, up 12.9%. Adjusted EBITDA grew 3.0% to $117.5 million. The company repurchased $150 million of outstanding shares during the quarter. For full year 2026, Option Care Health expects net revenue between $5.68 billion and $5.78 billion, with adjusted diluted earnings per share of $1.85 to $1.92. The company forecasts adjusted EBITDA of $480 million to $495 million and operating cash flow of at least $320 million.